XML 26 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated statements of cash flows - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from (used in) operating activities [abstract]      
Profit (loss) before tax R$ 5,448,556 R$ 4,985,967 R$ 3,936,348
Adjustments to reconcile profit (loss) [abstract]      
Adjustments for depreciation expense 140,977 125,193 118,603
Adjustments for amortisation expense 163,166 140,132 133,810
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss 23,358 29,452 32,266
Share of profit (loss) of associates and joint ventures accounted for using equity method (115,848) (47,286) (73,507)
Gains (losses) on financial assets measured at fair value through other comprehensive income, net of tax 75,564 91,212 52,403
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables 392,302 288,496 360,859
Adjustments for provisions 3,634 34,285 9,940
Adjustments for unrealised foreign exchange losses (gains) (980,862) 1,188,410 (470,788)
Adjustments for share-based payments 391,687 417,257 365,715
Adjustments for interest expense 547,058 609,375 637,640
Gains (losses) on disposals of investments 0 33,126 26,367
Losses on disposals of property, plant and equipment 3,795 0 0
Changes In Assets And Liabilities [Abstract]      
Adjustments For Increase decrease In Securities (41,163,391) (59,159,736) (12,743,703)
Adjustments for decrease (increase) in derivative financial assets 2,849,376 (7,340,657) 1,700,236
Adjustments for decrease (increase) in financial assets held for trading 4,134,930 (2,057,519) 1,209,000
Adjustments for decrease (increase) in reverse repurchase agreements and cash collateral on securities borrowed 8,512,297 (4,281,877) (4,495,605)
Adjustments for decrease (increase) in trade accounts receivable (638,809) (109,731) (53,247)
Adjustments for decrease (increase) in loans and advances to banks (5,251,571) (951,004) (5,596,362)
Adjustments for decrease (increase) in prepaid expenses 299,829 55,030 22,722
Adjustments for decrease (increase) in other assets (3,024,508) (8,083,216) (437,106)
Adjustments for increase (decrease) in repurchase agreements and cash collateral on securities lent (13,065,852) 38,439,210 711,818
Adjustments for increase (decrease) in trade accounts payable 46,693 (184,753) 326,344
Adjustments for increase (decrease) in deposits from banks 30,042,253 33,547,408 12,478,690
Adjustments For Increase decrease In Social And Statutory Obligations 54,342 164,784 126,692
Adjustments For Increase decrease In Tax And Social Security Obligations (75,931) (154,910) 17,407
Adjustments for increase (decrease) in employee benefit liabilities 26,799,035 9,815,312 10,675,260
Adjustments for increase (decrease) in other liabilities (2,724,055) 4,484,949 (347,790)
Cash flows from (used in) operations 12,888,025 12,078,909 8,724,012
Income tax paid (313,602) (542,404) (402,842)
Contingencies paid (52,637) (8,188) (52,667)
Interest paid (367,332) (349,353) (141,202)
Additional contigent consideration paid (109,628) 0 0
Cash flows from (used in) operating activities 12,044,826 11,178,964 8,127,301
Cash flows from (used in) investing activities [abstract]      
Purchase of intangible assets (280,282) (185,404) (130,219)
Purchase of property, plant and equipment (209,285) (144,808) (66,004)
Disposal of property and equipment assets 0 (10,000) 0
Cash flows used in obtaining control of subsidiaries or other businesses 0 0 770,887
Capital (contributions)/reductions in associates (14,406) 0 0
Acquisition of associates (335,056) (1,393,863) (65,444)
(Acquisition)/disposal of associates measured at fair value (50,628) 0 29,589
Other cash payments to acquire interests in joint ventures, classified as investing activities 144,880 46,812 0
Cash flows from (used in) investing activities (715,965) (1,667,263) 538,809
Cash flows from (used in) financing activities [abstract]      
Proceeds from borrowings 2,626,479 0 2,252,550
Increase (decrease) through treasury share transactions, equity (1,900,691) (1,353,611) (915,859)
Proceeds from issue of bonds, notes and debentures 0 1,159,233 373,481
Repayments of borrowings (3,891,323) (2,381,225) (1,966,674)
Repayments of bonds, notes and debentures (1,266,496) (1,170,612) (590,029)
Dividends paid (494,517) (2,037,082) (3,542,298)
Increase Decrease From Transactions With Non Controlling Interests 0 (5) (4,146)
Dividends paid to non-controlling interests (800) (991) (1,853)
Cash flows from (used in) financing activities (4,927,348) (5,784,293) (4,394,828)
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 6,401,513 3,727,408 4,271,282
Cash and cash equivalents at beginning of period 12,909,614 9,210,484 4,967,480
Effect of exchange rate changes on cash and cash equivalents (90,589) (28,278) (28,278)
Cash and cash equivalents at end of period 19,220,538 12,909,614 9,210,484
Cash 10,356,636 5,610,548 3,943,307
Reverse Repurchase Agreements And Cash Collateral On Securities Borrowed Included In Cash And Cash Equivalents 3,518,460 2,885,843 2,760,296
Short-term deposits, classified as cash equivalents 90,443 69,224 67,985
Other deposits R$ 5,254,999 R$ 4,343,999 R$ 2,438,896